nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—Cytochrome P450 3A4 Inhibitors—Cyclosporine—systemic lupus erythematosus	0.627	1	CiPCiCtD
Efavirenz—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0247	0.105	CbGbCtD
Efavirenz—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0223	0.095	CbGbCtD
Efavirenz—CYP2C19—Dapsone—systemic lupus erythematosus	0.0191	0.0814	CbGbCtD
Efavirenz—CYP2C9—Dapsone—systemic lupus erythematosus	0.0159	0.0677	CbGbCtD
Efavirenz—CYP2C19—Prednisone—systemic lupus erythematosus	0.0132	0.0564	CbGbCtD
Efavirenz—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.013	0.0555	CbGbCtD
Efavirenz—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0125	0.0535	CbGbCtD
Efavirenz—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0106	0.045	CbGbCtD
Efavirenz—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0104	0.0445	CbGbCtD
Efavirenz—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00953	0.0407	CbGbCtD
Efavirenz—CYP3A4—Dapsone—systemic lupus erythematosus	0.00923	0.0394	CbGbCtD
Efavirenz—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00826	0.0352	CbGbCtD
Efavirenz—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.008	0.0341	CbGbCtD
Efavirenz—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.008	0.0341	CbGbCtD
Efavirenz—CYP2C9—cardial valve—systemic lupus erythematosus	0.00691	0.309	CbGeAlD
Efavirenz—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00687	0.0293	CbGbCtD
Efavirenz—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00686	0.0293	CbGbCtD
Efavirenz—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00677	0.0289	CbGbCtD
Efavirenz—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00642	0.0274	CbGbCtD
Efavirenz—CYP3A4—Prednisone—systemic lupus erythematosus	0.0064	0.0273	CbGbCtD
Efavirenz—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00628	0.0268	CbGbCtD
Efavirenz—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00606	0.0259	CbGbCtD
Efavirenz—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00399	0.017	CbGbCtD
Efavirenz—CYP2C19—urine—systemic lupus erythematosus	0.00192	0.086	CbGeAlD
Efavirenz—CYP1A2—urine—systemic lupus erythematosus	0.00157	0.0702	CbGeAlD
Efavirenz—CYP2C9—urine—systemic lupus erythematosus	0.00149	0.0667	CbGeAlD
Efavirenz—CYP3A4—urine—systemic lupus erythematosus	0.00114	0.0508	CbGeAlD
Efavirenz—CYP2D6—urine—systemic lupus erythematosus	0.00112	0.05	CbGeAlD
Efavirenz—CYP2C19—blood plasma—systemic lupus erythematosus	0.001	0.0449	CbGeAlD
Efavirenz—CYP1A2—blood plasma—systemic lupus erythematosus	0.000819	0.0367	CbGeAlD
Efavirenz—CYP2B6—blood plasma—systemic lupus erythematosus	0.000785	0.0351	CbGeAlD
Efavirenz—CYP2C9—blood plasma—systemic lupus erythematosus	0.000778	0.0348	CbGeAlD
Efavirenz—CYP3A4—blood plasma—systemic lupus erythematosus	0.000593	0.0265	CbGeAlD
Efavirenz—CYP2D6—blood plasma—systemic lupus erythematosus	0.000583	0.0261	CbGeAlD
Efavirenz—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000405	0.0181	CbGeAlD
Efavirenz—CYP2B6—skin of body—systemic lupus erythematosus	0.000377	0.0169	CbGeAlD
Efavirenz—CYP2B6—kidney—systemic lupus erythematosus	0.000356	0.0159	CbGeAlD
Efavirenz—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000306	0.0137	CbGeAlD
Efavirenz—CYP3A4—kidney—systemic lupus erythematosus	0.000269	0.012	CbGeAlD
Efavirenz—CYP2D6—kidney—systemic lupus erythematosus	0.000264	0.0118	CbGeAlD
Efavirenz—CYP1A2—lung—systemic lupus erythematosus	0.000263	0.0118	CbGeAlD
Efavirenz—CYP2B6—lung—systemic lupus erythematosus	0.000252	0.0113	CbGeAlD
Efavirenz—CYP2B6—nervous system—systemic lupus erythematosus	0.000234	0.0105	CbGeAlD
Efavirenz—CYP2B6—central nervous system—systemic lupus erythematosus	0.000225	0.0101	CbGeAlD
Efavirenz—CYP3A4—nervous system—systemic lupus erythematosus	0.000176	0.00789	CbGeAlD
Efavirenz—CYP2D6—nervous system—systemic lupus erythematosus	0.000174	0.00777	CbGeAlD
Efavirenz—CYP3A4—central nervous system—systemic lupus erythematosus	0.00017	0.0076	CbGeAlD
Efavirenz—CYP2D6—central nervous system—systemic lupus erythematosus	0.000167	0.00748	CbGeAlD
Efavirenz—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.92e-05	0.000423	CcSEcCtD
Efavirenz—Pain—Prednisolone—systemic lupus erythematosus	4.89e-05	0.00042	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—systemic lupus erythematosus	4.89e-05	0.00042	CcSEcCtD
Efavirenz—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	4.87e-05	0.000419	CcSEcCtD
Efavirenz—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.86e-05	0.000417	CcSEcCtD
Efavirenz—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.85e-05	0.000417	CcSEcCtD
Efavirenz—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.85e-05	0.000417	CcSEcCtD
Efavirenz—Nausea—Leflunomide—systemic lupus erythematosus	4.84e-05	0.000416	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.83e-05	0.000415	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.82e-05	0.000414	CcSEcCtD
Efavirenz—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.82e-05	0.000414	CcSEcCtD
Efavirenz—Vision blurred—Prednisone—systemic lupus erythematosus	4.8e-05	0.000412	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.79e-05	0.000412	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.79e-05	0.000412	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.78e-05	0.000411	CcSEcCtD
Efavirenz—Pain—Hydrocortisone—systemic lupus erythematosus	4.78e-05	0.000411	CcSEcCtD
Efavirenz—Insomnia—Triamcinolone—systemic lupus erythematosus	4.76e-05	0.000409	CcSEcCtD
Efavirenz—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.75e-05	0.000408	CcSEcCtD
Efavirenz—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.73e-05	0.000406	CcSEcCtD
Efavirenz—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.72e-05	0.000406	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.71e-05	0.000405	CcSEcCtD
Efavirenz—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.71e-05	0.000405	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—systemic lupus erythematosus	4.71e-05	0.000405	CcSEcCtD
Efavirenz—Anaemia—Prednisone—systemic lupus erythematosus	4.71e-05	0.000405	CcSEcCtD
Efavirenz—Shock—Dexamethasone—systemic lupus erythematosus	4.7e-05	0.000404	CcSEcCtD
Efavirenz—Shock—Betamethasone—systemic lupus erythematosus	4.7e-05	0.000404	CcSEcCtD
Efavirenz—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.69e-05	0.000403	CcSEcCtD
Efavirenz—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.68e-05	0.000402	CcSEcCtD
Efavirenz—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.68e-05	0.000402	CcSEcCtD
Efavirenz—Agitation—Prednisone—systemic lupus erythematosus	4.68e-05	0.000402	CcSEcCtD
Efavirenz—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.67e-05	0.000402	CcSEcCtD
Efavirenz—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.67e-05	0.000402	CcSEcCtD
Efavirenz—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.66e-05	0.0004	CcSEcCtD
Efavirenz—Tachycardia—Betamethasone—systemic lupus erythematosus	4.66e-05	0.0004	CcSEcCtD
Efavirenz—Angioedema—Prednisone—systemic lupus erythematosus	4.65e-05	0.0004	CcSEcCtD
Efavirenz—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.63e-05	0.000398	CcSEcCtD
Efavirenz—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.63e-05	0.000398	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.62e-05	0.000397	CcSEcCtD
Efavirenz—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.62e-05	0.000397	CcSEcCtD
Efavirenz—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.61e-05	0.000396	CcSEcCtD
Efavirenz—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.61e-05	0.000396	CcSEcCtD
Efavirenz—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.6e-05	0.000396	CcSEcCtD
Efavirenz—Malaise—Prednisone—systemic lupus erythematosus	4.59e-05	0.000395	CcSEcCtD
Efavirenz—Vertigo—Prednisone—systemic lupus erythematosus	4.58e-05	0.000393	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—systemic lupus erythematosus	4.57e-05	0.000393	CcSEcCtD
Efavirenz—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.57e-05	0.000393	CcSEcCtD
Efavirenz—Syncope—Prednisone—systemic lupus erythematosus	4.57e-05	0.000392	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000392	CcSEcCtD
Efavirenz—Anorexia—Dexamethasone—systemic lupus erythematosus	4.55e-05	0.000391	CcSEcCtD
Efavirenz—Anorexia—Betamethasone—systemic lupus erythematosus	4.55e-05	0.000391	CcSEcCtD
Efavirenz—Urticaria—Prednisolone—systemic lupus erythematosus	4.54e-05	0.00039	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.54e-05	0.00039	CcSEcCtD
Efavirenz—Fatigue—Triamcinolone—systemic lupus erythematosus	4.53e-05	0.00039	CcSEcCtD
Efavirenz—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.52e-05	0.000389	CcSEcCtD
Efavirenz—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.52e-05	0.000388	CcSEcCtD
Efavirenz—Asthenia—Cyclosporine—systemic lupus erythematosus	4.51e-05	0.000388	CcSEcCtD
Efavirenz—Pain—Triamcinolone—systemic lupus erythematosus	4.5e-05	0.000387	CcSEcCtD
Efavirenz—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.48e-05	0.000385	CcSEcCtD
Efavirenz—Pruritus—Cyclosporine—systemic lupus erythematosus	4.45e-05	0.000382	CcSEcCtD
Efavirenz—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.44e-05	0.000381	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—systemic lupus erythematosus	4.44e-05	0.000381	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.42e-05	0.00038	CcSEcCtD
Efavirenz—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.42e-05	0.000379	CcSEcCtD
Efavirenz—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.42e-05	0.000379	CcSEcCtD
Efavirenz—Convulsion—Prednisone—systemic lupus erythematosus	4.41e-05	0.000379	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000379	CcSEcCtD
Efavirenz—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.4e-05	0.000378	CcSEcCtD
Efavirenz—Hypertension—Prednisone—systemic lupus erythematosus	4.4e-05	0.000378	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.35e-05	0.000374	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.35e-05	0.000374	CcSEcCtD
Efavirenz—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.34e-05	0.000373	CcSEcCtD
Efavirenz—Arthralgia—Prednisone—systemic lupus erythematosus	4.34e-05	0.000373	CcSEcCtD
Efavirenz—Myalgia—Prednisone—systemic lupus erythematosus	4.34e-05	0.000373	CcSEcCtD
Efavirenz—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.33e-05	0.000372	CcSEcCtD
Efavirenz—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.32e-05	0.000372	CcSEcCtD
Efavirenz—Anxiety—Prednisone—systemic lupus erythematosus	4.32e-05	0.000371	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000371	CcSEcCtD
Efavirenz—Insomnia—Dexamethasone—systemic lupus erythematosus	4.32e-05	0.000371	CcSEcCtD
Efavirenz—Insomnia—Betamethasone—systemic lupus erythematosus	4.32e-05	0.000371	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.31e-05	0.00037	CcSEcCtD
Efavirenz—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.3e-05	0.00037	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.29e-05	0.000369	CcSEcCtD
Efavirenz—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.29e-05	0.000368	CcSEcCtD
Efavirenz—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.29e-05	0.000368	CcSEcCtD
Efavirenz—Discomfort—Prednisone—systemic lupus erythematosus	4.28e-05	0.000368	CcSEcCtD
Efavirenz—Erythema—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000366	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000366	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.21e-05	0.000362	CcSEcCtD
Efavirenz—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.2e-05	0.000361	CcSEcCtD
Efavirenz—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.2e-05	0.000361	CcSEcCtD
Efavirenz—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.2e-05	0.000361	CcSEcCtD
Efavirenz—Urticaria—Triamcinolone—systemic lupus erythematosus	4.18e-05	0.000359	CcSEcCtD
Efavirenz—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.17e-05	0.000358	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000358	CcSEcCtD
Efavirenz—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.16e-05	0.000357	CcSEcCtD
Efavirenz—Dizziness—Cyclosporine—systemic lupus erythematosus	4.16e-05	0.000357	CcSEcCtD
Efavirenz—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.15e-05	0.000357	CcSEcCtD
Efavirenz—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.15e-05	0.000357	CcSEcCtD
Efavirenz—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.15e-05	0.000357	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.12e-05	0.000354	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.12e-05	0.000354	CcSEcCtD
Efavirenz—Back pain—Methotrexate—systemic lupus erythematosus	4.12e-05	0.000354	CcSEcCtD
Efavirenz—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.12e-05	0.000354	CcSEcCtD
Efavirenz—Fatigue—Betamethasone—systemic lupus erythematosus	4.11e-05	0.000354	CcSEcCtD
Efavirenz—Fatigue—Dexamethasone—systemic lupus erythematosus	4.11e-05	0.000354	CcSEcCtD
Efavirenz—Shock—Prednisone—systemic lupus erythematosus	4.09e-05	0.000351	CcSEcCtD
Efavirenz—Pain—Betamethasone—systemic lupus erythematosus	4.08e-05	0.000351	CcSEcCtD
Efavirenz—Pain—Dexamethasone—systemic lupus erythematosus	4.08e-05	0.000351	CcSEcCtD
Efavirenz—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.08e-05	0.00035	CcSEcCtD
Efavirenz—Tachycardia—Prednisone—systemic lupus erythematosus	4.06e-05	0.000349	CcSEcCtD
Efavirenz—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.05e-05	0.000348	CcSEcCtD
Efavirenz—Skin disorder—Prednisone—systemic lupus erythematosus	4.04e-05	0.000347	CcSEcCtD
Efavirenz—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.02e-05	0.000345	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—systemic lupus erythematosus	4.01e-05	0.000345	CcSEcCtD
Efavirenz—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.01e-05	0.000344	CcSEcCtD
Efavirenz—Vomiting—Cyclosporine—systemic lupus erythematosus	4e-05	0.000343	CcSEcCtD
Efavirenz—Rash—Cyclosporine—systemic lupus erythematosus	3.96e-05	0.000341	CcSEcCtD
Efavirenz—Anorexia—Prednisone—systemic lupus erythematosus	3.96e-05	0.00034	CcSEcCtD
Efavirenz—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.96e-05	0.00034	CcSEcCtD
Efavirenz—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.95e-05	0.00034	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000339	CcSEcCtD
Efavirenz—Headache—Cyclosporine—systemic lupus erythematosus	3.94e-05	0.000338	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000338	CcSEcCtD
Efavirenz—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.93e-05	0.000338	CcSEcCtD
Efavirenz—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.93e-05	0.000338	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.9e-05	0.000335	CcSEcCtD
Efavirenz—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.9e-05	0.000335	CcSEcCtD
Efavirenz—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.9e-05	0.000335	CcSEcCtD
Efavirenz—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.88e-05	0.000333	CcSEcCtD
Efavirenz—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.87e-05	0.000332	CcSEcCtD
Efavirenz—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.87e-05	0.000332	CcSEcCtD
Efavirenz—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.86e-05	0.000332	CcSEcCtD
Efavirenz—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.84e-05	0.00033	CcSEcCtD
Efavirenz—Malaise—Methotrexate—systemic lupus erythematosus	3.84e-05	0.00033	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—systemic lupus erythematosus	3.82e-05	0.000329	CcSEcCtD
Efavirenz—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.82e-05	0.000328	CcSEcCtD
Efavirenz—Urticaria—Dexamethasone—systemic lupus erythematosus	3.79e-05	0.000326	CcSEcCtD
Efavirenz—Urticaria—Betamethasone—systemic lupus erythematosus	3.79e-05	0.000326	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.79e-05	0.000325	CcSEcCtD
Efavirenz—Dizziness—Prednisolone—systemic lupus erythematosus	3.78e-05	0.000325	CcSEcCtD
Efavirenz—Asthenia—Triamcinolone—systemic lupus erythematosus	3.77e-05	0.000324	CcSEcCtD
Efavirenz—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.77e-05	0.000324	CcSEcCtD
Efavirenz—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.77e-05	0.000324	CcSEcCtD
Efavirenz—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.77e-05	0.000324	CcSEcCtD
Efavirenz—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.77e-05	0.000324	CcSEcCtD
Efavirenz—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.77e-05	0.000324	CcSEcCtD
Efavirenz—Insomnia—Prednisone—systemic lupus erythematosus	3.76e-05	0.000323	CcSEcCtD
Efavirenz—Nausea—Cyclosporine—systemic lupus erythematosus	3.73e-05	0.000321	CcSEcCtD
Efavirenz—Paraesthesia—Prednisone—systemic lupus erythematosus	3.73e-05	0.000321	CcSEcCtD
Efavirenz—Pruritus—Triamcinolone—systemic lupus erythematosus	3.72e-05	0.00032	CcSEcCtD
Efavirenz—Cough—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000319	CcSEcCtD
Efavirenz—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.71e-05	0.000319	CcSEcCtD
Efavirenz—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.69e-05	0.000317	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000317	CcSEcCtD
Efavirenz—Dyspepsia—Prednisone—systemic lupus erythematosus	3.66e-05	0.000314	CcSEcCtD
Efavirenz—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.64e-05	0.000313	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000311	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000311	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000311	CcSEcCtD
Efavirenz—Decreased appetite—Prednisone—systemic lupus erythematosus	3.61e-05	0.00031	CcSEcCtD
Efavirenz—Rash—Prednisolone—systemic lupus erythematosus	3.61e-05	0.00031	CcSEcCtD
Efavirenz—Dermatitis—Prednisolone—systemic lupus erythematosus	3.6e-05	0.00031	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.6e-05	0.000309	CcSEcCtD
Efavirenz—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.59e-05	0.000309	CcSEcCtD
Efavirenz—Fatigue—Prednisone—systemic lupus erythematosus	3.58e-05	0.000308	CcSEcCtD
Efavirenz—Headache—Prednisolone—systemic lupus erythematosus	3.58e-05	0.000308	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000308	CcSEcCtD
Efavirenz—Constipation—Prednisone—systemic lupus erythematosus	3.55e-05	0.000305	CcSEcCtD
Efavirenz—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.55e-05	0.000305	CcSEcCtD
Efavirenz—Rash—Hydrocortisone—systemic lupus erythematosus	3.52e-05	0.000303	CcSEcCtD
Efavirenz—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.52e-05	0.000302	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000301	CcSEcCtD
Efavirenz—Headache—Hydrocortisone—systemic lupus erythematosus	3.5e-05	0.000301	CcSEcCtD
Efavirenz—Dizziness—Triamcinolone—systemic lupus erythematosus	3.48e-05	0.000299	CcSEcCtD
Efavirenz—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.47e-05	0.000298	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.43e-05	0.000294	CcSEcCtD
Efavirenz—Asthenia—Dexamethasone—systemic lupus erythematosus	3.42e-05	0.000294	CcSEcCtD
Efavirenz—Asthenia—Betamethasone—systemic lupus erythematosus	3.42e-05	0.000294	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000293	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.4e-05	0.000292	CcSEcCtD
Efavirenz—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.4e-05	0.000292	CcSEcCtD
Efavirenz—Nausea—Prednisolone—systemic lupus erythematosus	3.4e-05	0.000292	CcSEcCtD
Efavirenz—Pruritus—Dexamethasone—systemic lupus erythematosus	3.38e-05	0.00029	CcSEcCtD
Efavirenz—Pruritus—Betamethasone—systemic lupus erythematosus	3.38e-05	0.00029	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—systemic lupus erythematosus	3.37e-05	0.00029	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000289	CcSEcCtD
Efavirenz—Vomiting—Triamcinolone—systemic lupus erythematosus	3.34e-05	0.000287	CcSEcCtD
Efavirenz—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.34e-05	0.000287	CcSEcCtD
Efavirenz—Nausea—Hydrocortisone—systemic lupus erythematosus	3.32e-05	0.000285	CcSEcCtD
Efavirenz—Rash—Triamcinolone—systemic lupus erythematosus	3.32e-05	0.000285	CcSEcCtD
Efavirenz—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.31e-05	0.000285	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—systemic lupus erythematosus	3.31e-05	0.000285	CcSEcCtD
Efavirenz—Rash—Methylprednisolone—systemic lupus erythematosus	3.31e-05	0.000284	CcSEcCtD
Efavirenz—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.31e-05	0.000284	CcSEcCtD
Efavirenz—Urticaria—Prednisone—systemic lupus erythematosus	3.3e-05	0.000284	CcSEcCtD
Efavirenz—Headache—Triamcinolone—systemic lupus erythematosus	3.3e-05	0.000283	CcSEcCtD
Efavirenz—Headache—Methylprednisolone—systemic lupus erythematosus	3.29e-05	0.000283	CcSEcCtD
Efavirenz—Abdominal pain—Prednisone—systemic lupus erythematosus	3.29e-05	0.000282	CcSEcCtD
Efavirenz—Body temperature increased—Prednisone—systemic lupus erythematosus	3.29e-05	0.000282	CcSEcCtD
Efavirenz—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.27e-05	0.000281	CcSEcCtD
Efavirenz—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.27e-05	0.000281	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000272	CcSEcCtD
Efavirenz—Dizziness—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.000271	CcSEcCtD
Efavirenz—Dizziness—Betamethasone—systemic lupus erythematosus	3.16e-05	0.000271	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—systemic lupus erythematosus	3.14e-05	0.00027	CcSEcCtD
Efavirenz—Nausea—Triamcinolone—systemic lupus erythematosus	3.12e-05	0.000268	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.12e-05	0.000268	CcSEcCtD
Efavirenz—Nausea—Methylprednisolone—systemic lupus erythematosus	3.12e-05	0.000268	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000266	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—systemic lupus erythematosus	3.09e-05	0.000265	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.06e-05	0.000263	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000263	CcSEcCtD
Efavirenz—Vomiting—Betamethasone—systemic lupus erythematosus	3.03e-05	0.000261	CcSEcCtD
Efavirenz—Vomiting—Dexamethasone—systemic lupus erythematosus	3.03e-05	0.000261	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.02e-05	0.000259	CcSEcCtD
Efavirenz—Rash—Dexamethasone—systemic lupus erythematosus	3.01e-05	0.000259	CcSEcCtD
Efavirenz—Rash—Betamethasone—systemic lupus erythematosus	3.01e-05	0.000259	CcSEcCtD
Efavirenz—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.01e-05	0.000258	CcSEcCtD
Efavirenz—Dermatitis—Betamethasone—systemic lupus erythematosus	3.01e-05	0.000258	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3e-05	0.000258	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000257	CcSEcCtD
Efavirenz—Headache—Dexamethasone—systemic lupus erythematosus	2.99e-05	0.000257	CcSEcCtD
Efavirenz—Headache—Betamethasone—systemic lupus erythematosus	2.99e-05	0.000257	CcSEcCtD
Efavirenz—Asthenia—Prednisone—systemic lupus erythematosus	2.98e-05	0.000256	CcSEcCtD
Efavirenz—Pain—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000255	CcSEcCtD
Efavirenz—Pruritus—Prednisone—systemic lupus erythematosus	2.94e-05	0.000253	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000246	CcSEcCtD
Efavirenz—Diarrhoea—Prednisone—systemic lupus erythematosus	2.84e-05	0.000244	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000244	CcSEcCtD
Efavirenz—Nausea—Betamethasone—systemic lupus erythematosus	2.83e-05	0.000244	CcSEcCtD
Efavirenz—Nausea—Dexamethasone—systemic lupus erythematosus	2.83e-05	0.000244	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000237	CcSEcCtD
Efavirenz—Dizziness—Prednisone—systemic lupus erythematosus	2.75e-05	0.000236	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.75e-05	0.000236	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.75e-05	0.000236	CcSEcCtD
Efavirenz—Vomiting—Prednisone—systemic lupus erythematosus	2.64e-05	0.000227	CcSEcCtD
Efavirenz—Rash—Prednisone—systemic lupus erythematosus	2.62e-05	0.000225	CcSEcCtD
Efavirenz—Dermatitis—Prednisone—systemic lupus erythematosus	2.62e-05	0.000225	CcSEcCtD
Efavirenz—Headache—Prednisone—systemic lupus erythematosus	2.6e-05	0.000224	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.56e-05	0.00022	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—systemic lupus erythematosus	2.49e-05	0.000214	CcSEcCtD
Efavirenz—Nausea—Prednisone—systemic lupus erythematosus	2.47e-05	0.000212	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000211	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000204	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000197	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—systemic lupus erythematosus	2.21e-05	0.00019	CcSEcCtD
Efavirenz—Rash—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000188	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000188	CcSEcCtD
Efavirenz—Headache—Methotrexate—systemic lupus erythematosus	2.18e-05	0.000187	CcSEcCtD
Efavirenz—Nausea—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000177	CcSEcCtD
